Learn More
Invitrogen™ SARS Coronavirus Nucleocapsid Polyclonal Antibody

Description
The immunogen is 94%(15/16) homologous to SARS-COV-2 (COVID-19) Nucleocapsid protein. The cross reactivity is not empirically tested. The antibody was tested on a cell line transfected with full-length SARS Nucleocapsid cDNA with a predicted molecular weight of 46 kDa. Suggested positive control: transfected mouse melanoma cell lysate. Immunogen sequence: IGYYRRATRR IRGGDG.
Specifications
Specifications
| Antigen | SARS Coronavirus Nucleocapsid |
| Applications | ELISA, Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.05% sodium azide |
| Gene Alias | Coronavirus; COVID; COVID 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Nucleocapsid; SARS-CoV2; SARS-CoV-2 |
| Host Species | Rabbit |
| Immunogen | Synthetic peptide corresponding to amino acids 84-99 from the N (SARS Nucleocapsid) for the Human SARS coronavirus. |
| Purification Method | Protein A |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.